The Meningococcal Vaccine Market is projected to witness substantial growth through 2034, driven by rising immunization programs, continuous advances in vaccine development, increasing awareness of meningococcal disease prevention, and expanding government healthcare initiatives worldwide. Meningococcal disease, caused by Neisseria meningitidis, remains a serious global public health concern...